ARTICLE | Company News
Coulter and Cobra to develop gene expression technology
October 3, 2000 7:00 AM UTC
CLTR and Cobra Therapeutics, a subsidiary of ML Laboratories (LSE:MLB), will collaborate to develop and commercialize Cobra's gene expression technology. Cobra's Ubiquitous Chromatin Opening Elements ...